Pure Biologics (PUR.WA) Stock Price
Pure Biologics Price
Revenue at Pure Biologics has contracted by 31.1% per year over the past 7 years to 95,000.00 PLN. Pure Biologics's net margin stands at -37,572.6%, down from -28.1% several years earlier.
Pure Biologics stock price
Pure Biologics business model & stock analysis
Frequently asked questions about Pure Biologics
Converted at the current exchange rate, the Pure Biologics share trades at 0.35 EUR (1.53 PLN).
The Pure Biologics share (PUR.WA) is listed on 4 stock exchanges, including: Frankfurt (PQB.F), München (PQB.MU).
The revenue cannot currently be calculated for Pure Biologics.
The profit cannot currently be calculated for Pure Biologics.
The P/E ratio cannot be calculated for Pure Biologics at the moment.
The P/S cannot be calculated for Pure Biologics currently.
The Eulerpool Quality Score for Pure Biologics is 2/10.
The ISIN of Pure Biologics is PLPRBLG00010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Pure Biologics is A2N9NP. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Pure Biologics is PUR.WA. The ticker symbol is used to trade Pure Biologics shares on the stock exchange.
Pure Biologics stock
Pure Biologics Peer Group
Pure Biologics Ticker
Pure Biologics FIGI
All fundamentals and in-depth analysis of Pure Biologics
Our stock analysis for Pure Biologics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pure Biologics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.